Logo Prima Biomed


Welcome to the Newsroom

03 July 2017

Final Prospectus Supplement


ENGLISH

SYDNEY, AUSTRALIA - Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD) (“Prima” or the
“Company”) announces that it filed with the SEC on Friday 30th June 2017, the attached
final Prospectus Supplement.

 

(...)